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Abstract  
 Increasing clinical and industrial advances in the pharmaceutical world requires 
technological improvements in cell culture development and monoclonal antibody (mAb) 
production. Experiments performed with Chinese Hamster Ovary (CHO) cells producing mAbs, 
have shown enhanced titers with a certain feed strategy. However implementing a feedback 
control system is not preferable for large-scale manufacturing. In this paper, a method to create 
feed-forward control with BioXpert, SCADA software is presented. The results are not 
conclusive since there were no replicates to demonstrate reproducibility. Assuming that the 
results are correct, it may be concluded that feed-forward control system was successfully 
implemented on the fed-batch bioreactors via BioXpert software by using feed profiles generated 
from previous feedback experiments. Titer results obtained from BioXpert feed-forward 
experiments yielded higher results than manual feed-forward experiments and similar to previous 
feedback experiments. For future work, it is recommended to repeat BioXpert feed-forward 
experiment with two or more replicates maintaining the same cell line and using more frequent 
feeding schedule by keeping total daily feeding amount the same. 
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Executive Summary 
 In this report, feed-forward control of nutrient feed via supervisory control and data 
acquisition (SCADA) software, BioXpert is presented. Previous feedback experiments 
performed by Keith Cochran at Abbott Bioresearch Center yielded high titer results; however, 
implementing the feedback control system is not very preferable in large-scale manufacturing. 
Therefore, a feed-forward control system to regulate flow of nutrient feed by using feed profiles 
generated from previously performed feedback experiments was created on BioXpert. During the 
experiments, 3L Applikon glass autoclavable reactors with Applikon ADI 1035 bio console, 
Applikon ADI 1030 bio controller, Sartorius TE series analytical balances and a computer with 
BioXpert NT version 2.25.091 were used. 
 Methodology that was followed was to use BioXpert to feed bioreactors based on 
previously developed nutrient feed profiles. In order to achieve that, a method was developed 
after performing several leading experiments, namely 1) Calibration of tubing and feed pumps 2) 
A run without cells or “dry run” and 3) An actual bioreactor run with cells fed using a BioXpert 
preprogrammed profile. After performing the preliminary experiments, an actual BioXpert 
experiment was performed with fed-batch bioreactors containing Chinese Hamster Ovary (CHO) 
cells, which produce monoclonal antibodies (mAbs). 
 Due to the small amount of feed that needs to be delivered into the bioreactors, 
Masterflex tubing with 1.6 mm internal diameter was used throughout the experiments. During 
the tubing calibration, it was expected to see deterioration in the tubing due to use. Therefore, 
flow rate of „new‟ and „used‟ (in BioXpert run with CHO cells of seven days of feeding) portions 
of tubing were measured and it was determined that performance of the tubing remained 
constant. Prior to performing experiments with CHO cells, pumps were calibrated. After testing 
accuracy of calibrating method, actual BioXpert experiments were performed. Pre-scheduled 
feeding program was used to pump desired amount of feed solution to fed-batch bioreactors 
when the VCD surpassed 3
 
million viable cells/mL. BioXpert algorithm was created for both 
reactors for a feeding schedule of three times per day for seven days. The feeding schedule 
presented in Table 1 was followed for the reactor II with three times per day feeding (every 8 
hours).   
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Table 1- Feeding schedule for reactor II 
 
 
 
 
 
 
 Starting on the first day of inoculation the bioreactor was sampled daily to obtain 
readings for pH, pO2 (mmHg), pCO2 (mmHg), glucose (g/L), lactate (g/L), viable cell density 
(viable cells/ml), viability (%) and osmolality (mOsm). From day 9, sample was retained for 
protein analysis.  
 To determine effect of BioXpert in implementing feed-forward control to fed-batch 
bioreactors, experimental results were compared with previously performed feedback and 
manual feed-forward experiments. Daily total feed amount was kept constant for these 
experiments; however, they yielded different results due to distinct feeding strategies. The 
feedback experiments were sampled and fed every 2 hours (12 times per day) with unequal feed 
amounts. The feed amounts were determined after the glucose analysis done during the 
sampling. During the manual feed-forward experiments, bioreactors were fed once daily with 
total amount of feed weight. For BioXpert experiment, the daily feed amount was divided into 
three equal smaller amounts and fed to the bioreactor every 8 hours (3 times per day). For the 
control run, the bioreactors were fed with glucose. In figure 1, the growth curves produced from 
these experiments are displayed. It may be seen that the BioXpert feed-forward experiment, 
being just a little bit above the control run, resulted in cell densities higher than manual feed-
forward experiments and lower than feedback experiments.  
Day 
Daily Feed 
Weight (g) 
Shots 
per day 
Feed Weight per 
Shot (g) 
“ON” Duration 
of Pump (sec) 
1 5.95 3 1.98 65 
2 7.78 3 2.59 85 
3 9.52 3 3.17 104 
4 10.39 3 3.46 113 
5 6.18 3 2.06 68 
6 4.44 3 1.48 49 
7 2.65 3 0.88 30 
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Figure 1- Growth curves 
 
 Another way to compare results with previous experiments was to use titer results. Figure 
2 shows the comparison of titer results between BioXpert experiment and previously performed 
feedback and manual feed-forward experiments. It may be seen that the feedback and BioXpert 
feed-forward experiments yielded to high titer results, which are similar however, manual feed-
forward experiment had lower titer values than the others. 
 
Figure 2- Titer results 
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 The results presented above are not conclusive since there are no replicates demonstrating 
reproducibility of BioXpert feed-forward experiment. Assuming that results are reproducible, 
BioXpert algorithm improved titer results of feed-forward strategy. For future work, it is 
recommended to perform BioXpert experiments with more than two replicates, maintaining 
current cell line and feed using feed strategy used for previous feedback experiments (12 times 
daily). 
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1 Introduction  
 Clinical and industrial advances in the pharmaceutical manufacturing have been 
increasing greatly over the last few years. According to the Journal of Commercial 
Biotechnology, the market size for monoclonal antibodies (mAbs) was expected to reach 30 
billion dollars in 2013 [1]. The increase in demand for antibody production emphasizes need for 
technological improvements in cell culture development and manufacturing of mAbs [2]. 
However, working with mammalian cell culture is challenging due to several considerations that 
need to be taken into account. Selection of bioreactor operating mode as well as amount and 
concentration of feed has a great effect on antibody production performance. Prior to large scale 
cell culture manufacturing, specific feed amounts and timing must be tested for a specific cell 
line.  
 Previous feed-back control experiments carried in the Process Sciences group at Abbott 
Bioresearch Center by Keith Cochran, yielded increased cell peak densities and titer. 
Unfortunately, the need to frequently sample the bioreactor (and the increased likelihood of 
contamination) for the feedback control scheme, makes this approach incompatible with a robust 
large scale manufacturing process. Because of this, a feed-forward scheme that follows the 
feeding profiles generated by the feedback fed-batch system is developped. 
 The goal of the project was to implement a feed-forward control mechanism to regulate 
flow of the feed by using the feed profiles generated by previously performed feed-back 
experiments. BioXpert software was used to control the feeding schedule. 
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2 Background Research  
 In the background research section of the report, discussion of previously work done on 
monoclonal antibodies (mAbs), Chinese Hamster Ovary (CHO) cells, fed-batch systems, process 
control systems and Supervisory Control And Data Acquisition (SCADA) systems is presented. 
 
2.1 Monoclonal Antibodies (mAbs) 
 Monoclonal antibodies (mAbs), largely used in biomedical research, diagnosis and 
therapy of diseases, are identical proteins derived from same type of immune cell [3]. They have 
two important characteristics making them useful in pharmaceuticals world; 1) they are target 
specific; each antibody is able to recognize one antigen and attack it, 2) they become active when 
triggered by a specific antigen and stay active for the rest of their  lifespan [4]. 
 In 1975, with presentation of “production of antibodies of predefined specificity” idea by 
Kohler and Milstein, mAbs were introduced to biotechnological world. In their paper, Kohler 
and Milstein‟s mentioned possibility of producing antibodies, which are capable of attacking 
specific antigens [5]. After that milestone finding, studies on mAb manufacturing have been 
increasing greatly. Currently, two methods, used with in vivo and in vitro techniques, are applied 
for the production of mAbs: 1) cell lines and 2) clones. The cell line method, displayed in Figure 
1,  includes production of immortalized tumor cell, which is called hybridoma [3]. First, tumor 
cells introduced to mouse, start growth of B cells containing antitumor antibodies. Later, these 
cells are combined with immortalized myeloma cells to create immortalized antibody producing 
hybrid cells. Production of fused cells produces several hybrids containing different antibodies. 
The hybrid cell, which is capable of making desired antibody is selected among the others and 
used for further processes [6]. For clone technique, isolation of B cells and tissue culture or 
immunization of individuals are not necessary. Immunoglobulin (Ig) genes are immortalized as 
opposed to cells, which are immortalized in cell line production. In this technique yeast or 
viruses are used instead of mice, which are used for the previous method [7].  
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Figure 1- Monoclonal Antibody Production [6] 
 
2.2 Chinese Hamster Ovary (CHO) Cells 
 Animal cell cultures have been used extensively for almost a decade in the 
pharmaceutical world. Interest towards mammalian cell cultures started in 1950‟s to meet 
increased demand for human vaccines [8]. Twenty to thirty years later, studies on recombinant 
protein technology became popular and for these researches, complex mammalian cell 
mechanisms, with post-translational metabolic machinery, were necessary. Currently, they are 
extensively used for production of advanced recombinant therapeutics such as recombinant 
proteins, mAbs and nucleic-acid base products [9].  
 There are several mammalian hosts cells, which can be used in production of proteins; 
such as mouse myelomas (NS0 and SP2/0), baby hamster kidney (BHK) [10], human embryonic 
kidney (HEK-293) and human-retina-derived (PER-C6). However, CHO cells are preferred 
among the other cell cultures since their cell metabolism shows similar characteristics to human 
cells. Additionally, it has been proven that they improve production capacity of recombinant 
proteins [9] and they are “capable of incorporating the appropriate post-translational 
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modifications, while at the same time maintaining the characteristics ideal for production 
culture”1 [10]. 
  In 1950‟s, CHO cells were obtained from a Chinese hamster (Cricetulus griseus) ovary 
epithelial tumor [11]. In 1986, tissue plasminogen activator (tPA) harvested from CHO cells by 
Genentech, S. San Francisco, CA, USA,  was approved for therapeutic use [12]. Since 1980‟s the 
productivity of the mammalian cells increased extensively. Enhanced cell technologies along 
with modified culture processes improved protein production from the CHO cells. Currently it is 
possible to harvest titers of up to 10g/L of recombinant protein [13]. Whereas, 10 years ago the 
titer amount was 50-100 mg/L [10]. Figure 2 displays a comparison between the protein 
production from CHO cells in 2004 and 1986. As it can be seen from the Figure 2a, viable cell 
concentration reached 100x10
5
 viable cells/mL in 2004 and the same parameter stayed under 
30x10
5
 viable cells/mL in 1986. In addition, at the process performed in 1986, the viability 
percentage of CHO cells decreased drastically between 100 and 200 hours to 60%, whereas in 
2004 process, it did not drop to the same low percentage until the 500
th
 hour. A similar trend of 
low values from 1986 and high values from 2004 can be observed from Figure 2b, which 
displays the titer results [12]. 
 
 
 
 
 
 
 
Figure 2- Comparison of CHO cell culture process in 1986 and 2004 [12] 
                                               
1 Allison, D.W., et al., Deciphering the Mechanisms of Therapeutic Protein Production. Society for Biological 
Engineering, 2007: p. 48-52. 
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2.3 Fed-batch System 
 Performance of biological process is affected by operating mode of bioreactor. While 
selecting the mode, economic cost, high yield, purity and low pollution are factors that should be 
paid attention to. Also the bioreactor mode depends on reaction kinetics and product capacity of 
the batch. In 1998, Bibila and Robinson reported that fed-batch system is one of the best reactor 
modes for the production of mAbs from CHO cells due to “its operational simplicity, reliability, 
and flexibility for implementation in multipurpose facilities
2” [14].  
 In batch culture, cells grow in a vessel where an initial charge of nutrients is supplied at 
once. There is no further addition or removal after time zero, and product accumulate into the 
bioreactor with waste material. Nevertheless in the fed-batch operation, which is also called 
semi-batch mode,  medium is fed at various times as opposed to feeding at time zero [15]. Figure 
3  shows the generic view of a fed-batch bioreactor. 
 
Figure 3- Fed-batch bioreactor 
 
 When compared to batch mode, fed-batch mode yield increased titer and higher cell 
viability [14]. Figure 4 displays plots comparing batch culture of NSO cell line to the fed-batch 
mode of the same cell line for viability and mAb production. For both Figure 4a (batch mode) 
and 4b (fed-batch mode), empty squares (□) and filled circles (●) represent mAb production and 
viable cell concentration as a function of time, respectively. From the plots, it may be determined 
                                               
2 Bibila, T.A. and D.K. Robinson, In pursuit of the optimal fed-batch process for monoclonal antibody production. 
Biotechnol. Prog., 1995. 11(1): p. 1-13. 
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that the maximum viable cell concentration is lower in batch culture than fed-batch mode. 
Furthermore, the mAb concentration from the fed-batch system reached 1.8g/L whereas the one 
from the batch mode was only 0.15 g/L  [14].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- Comparison between batch and fed-batch modes [13] 
  
 Other than batch and fed-batch systems, perfusion mode is used as an alternative method 
for cell culture. In the batch and fed-batch system, waste material is not removed from the vessel 
until the end of batch. Nevertheless in the perfusion systems, cell debris and inhibitory by-
products as well as enzyme produced by dead cells are removed. Since the by-products inhibit 
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product formation, their removal is likely to enhance protein production. As opposed to that 
advantage, there are several disadvantages of the perfusion operating mode. Nutrients are not 
completely used in these systems, therefore they are less cost effective than fed-batch and batch 
modes. Additionally, batch and/or fed-batch reactors are easier to implement to an existing 
facility than perfusion systems, which have high analytical costs and potential regulatory 
problems. Finally, long cycle period as well as risk of contamination and generic drift in 
perfusion systems, make the fed-batch and batch bioreactors more preferable [15].  
 
2.4 Process Control Systems          
 Maintaining an optimum bioreactor environment enhances the performance of cell 
culture therefore control systems are used to regulate values of temperature, pH and levels of 
dissolved gas in bioreactors.  
 While describing control systems, two definitions need to be given; input, which is 
stilmulus or command applied to process, and output, which is response of system to input [16]. 
Feed-forward and feedback are two type of control system configurations. In the feedback 
method, displayed in Figure 5, output coming out of processor is sent to feedback controller 
where it is compared to set-point value, which is previously defined to system. Based on 
divergence from the desired value, corrective action is taken by the control mechanism. However 
in the feed-forward system, the output has not effet on the input as it can be seen from Figure 6. 
Necessary deviations are predicted and regulatory action is taken before the process happens 
[17]. 
 
Figure 5- Feedback control system 
.  
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Figure 6- Feed-forward control system 
 
2.5 Supervisory Control and Data Acquisition (SCADA) 
 A Supervisory Control And Data Acquisition (SCADA) system, is usually implemented 
on top of a real-time control. SCADA system gathers data from different sensors and collects 
them in a central computer managing data and control system. Water management, electric 
power, traffic signals, mass transit, environmental control and manufacturing systems are 
examples of industries using SCADA systems [18]. 
 The SCADA system consists of a signal hardware with input and output, controllers, 
networks, a user interface called “human machine interface” (HMI), a software and a 
communication equipment. The main unit of the system is remote terminal unit (RTE), which is 
a programmable logic converter set to design requirements. Usually the SCADA system 
monitors and makes necessary changes automatically but it also allows for human intervention. 
The data collected in real time by the SCADA sensors are sent to the RTE where they are 
processed, and the RTE regulates changes if necessary. The data collected by the system are also 
displayed to user, who could make further modifications [18]. Also the system is able to plot 
measured variables on-line and display tables with information about data points, set points and 
process variables [19].  
 The pharmaceutical manufacturing industry is one of the fields where the SCADA 
systems are highly used. An article published at Genetic Engineering and Biotechnology News, 
reported that SCADA system becomes especially useful when bench-scale stirred tank 
bioreactors (STBRs) are in use. It has been mentioned that data from the STBRs need to be 
manually gathered at the absence of SCADA system [19] 
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 One example of a SCADA package is BioXpert, a software designed by Applikon Inc. 
for biotechnologists, which enables researchers to control and optimize their biological 
processes. BioXpert can be used to collect data and manage bioreactors and fermenters [20]. 
Using the BioXpert online control system, optimum values for several design parameters, such 
as temperature, pH, dissolved gas levels, operation of pumps, can be regulated. Detailed 
information on running the BioXpert software is attached at Appendix 2.   
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3 Methodology         
 The approach was to use BioXpert, a SCADA software, to feed bioreactors based on 
previously developed concentrated nutrient feed profiles. In this manner, three sets of 
experiments were performed: 1) Calibration of tubing and feed pumps 2) A run without cells or 
“dry run” and 3) An actual bioreactor run with cells fed using a BioXpert preprogrammed 
profile. 
 
3.1 Experimental Procedure   
 The experiments listed above were all conducted at the Abbott Bioresearch Center 
(ABC), 100 Research Drive, Worcester, MA. 3L Applikon glass autoclavable reactors with a 
working volume of 1.5 L, Applikon ADI 1030 biocontroller, Applikon ADI 1035 bio console 
and Sartorius TE series analytical balances were used for the experiments. Furthermore a 
computer with BioXpert NT version 2.25.091 was used. 
 
3.1.1 BioXpert Run with CHO Cells 
 After testing performance of the calibration curves, which are explained in section 4 of 
the report, an actual BioXpert run with live mAb-producing CHO cells was started to use a pre-
scheduled feeding profile. The feeding schedule was used for pumping desired amount of 
nutrient feed to fed-batch bioreactors using the experimental set-up shown in Figure 7. 
  A nutrient feed bottle located on a scale to verify the feeding amount was attached to 
bioreactor. Another bottle containing sodium hydroxide solution regulating the pH in the vessel 
was linked to the vessel. Two reactors were filled with media on March 12, 2008 and controls for 
regulating temperature, pH and oxygen were started. The next day, both reactors were inoculated 
with CHO cells. 
 
11 
 
Figure 7- Experimental set-up of BioXpert run with CHO cells 
 
 After the inoculation, each bioreactor was sampled daily and results were recorded in run 
sheets following protocol given: 
1. Record date, time, and experiment day to the run sheet.  
2. Document readings from the console for pH, temperature (oC) and dissolved 
oxygen (%) to the run sheet. 
3. Take out 10 mL of purge and 5 mL of sampling material with a syringe.  
4. Introduce sampling material into Radiometer ABL5 blood gas analyzer (BGA) for 
measurements of pH, pO2 (mmHg) and pCO2 (mmHg). 
5. Introduce sampling material into YSI 2700 Select Glucose & Lactate Analyzer for 
measurements of glucose (g/L) and lactate (g/L).  
6. Transfer the sampling material to a test tube from the syringe.  
7. Insert 1 mL of sampling material into Cell Density Examination (CEDEX) AS20 
system, which is developed by Innovatis, to receive viable cell density (viable 
cells/ml) and viability (%) results. 
Feed 
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8. Pipette 0.25 mL of sampling material to Advanced Instruments Osmometer 3900 
cassette for osmolality (mOsm) reading. 
9. From day 9, start retaining the sampling material for protein analysis. Place the 
solution into two small test tubes with similar weights and centrifuge it for 5 
minutes at 1200 rpm to precipitate the cells. Later, freeze the supernatant at -80
o
C 
and discard remaining suspension. 
  
 Details about the analyses, method and machines used for the tests listed above, namely 
Radiometer ABL5 blood gas analyzer, YSI 2300 STAT Plus Glucose & Lactate Analyzer, Cell 
Density Examination (CEDEX) system and Advanced Instruments Osmometer 3900 are attached 
as Appendix 3. 
 To create the BioXpert algorithm, daily feed amounts obtained from previously 
performed feedback experiments were divided in three and duration of feeding was calculated 
using the calibration curves. It was decided to start the feeding schedule when viable cell density 
surpassed 3 million viable cells/mL. However, reactor I never reached the desired amount of 
viable cells since its pH and temperature controls of were turned off on day 5 (data not shown). 
Therefore, the feed program, presented in Table 1, was only applied to reactor II starting on day 
6.  
Table 1- Feed schedule for reactor II 
Day 
Shots per 
day 
Daily total feed 
(g) 
Feed weight per 
shot (g) 
Feeding duration 
(sec) 
1 3 5.95 1.98 65 
2 3 7.78 2.59 85 
3 3 9.52 3.17 104 
4 3 10.39 3.46 113 
5 3 6.18 2.06 68 
6 3 4.44 1.48 49 
7 3 2.65 0.88 30 
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 Using the feeding duration information, BioXpert program, displayed in Table 2, for 
monitoring flow of concentrated nutrient feed to the fed-batch bioreactor was created. Feeding 
continued for seven days and samples were taken until the last day of feeding, which was day 13.  
Table 2- BioXpert algorithm used in actual run 
Control statement Starting time Ending time 
pmp1=0 0:00 0:01 
pmp1=pulse(59) 0:01 0:02 
pmp1=pulse(6) 0:02 0:03 
pmp1=pulse(59) 8:00 8:01 
pmp1=pulse(6) 8:01 8:02 
pmp1=pulse(59) 16:00 16:01 
pmp1=pulse(6) 16:01 16:02 
pmp1=pulse(59) 24:00 24:01 
pmp1=pulse(26) 24:01 24:02 
pmp1=pulse(59) 32:00 32:01 
pmp1=pulse(26) 32:01 32:02 
pmp1=pulse(59) 40:00 40:01 
pmp1=pulse(26) 40:01 40:02 
pmp1=pulse(59) 48:00 48:01 
pmp1=pulse(45) 48:01 48:02 
pmp1=pulse(59) 56:00 56:01 
pmp1=pulse(45) 56:01 56:02 
pmp1=pulse(59) 64:00 64:01 
pmp1=pulse(45) 64:01 64:02 
pmp1=pulse(59) 72:00 72:02 
pmp1=pulse(54) 72:02 72:03 
pmp1=pulse(59) 80:00 80:02 
pmp1=pulse(54) 80:02 80:03 
pmp1=pulse(59) 88:00 88:02 
pmp1=pulse(54) 88:02 88:03 
pmp1=pulse(59) 96:00 96:01 
pmp1=pulse(9) 96:01 96:02 
pmp1=pulse(59) 104:00 104:01 
pmp1=pulse(9) 104:01 104:02 
pmp1=pulse(59) 112:00 112:01 
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pmp1=pulse(9) 112:01 112:02 
pmp1=pulse(49) 120:00 120:01 
pmp1=pulse(49) 128:00 128:01 
pmp1=pulse(49) 136:00 136:01 
pmp1=pulse(30) 144:00 144:01 
pmp1=pulse(30) 152:00 152:01 
pmp1=pulse(30) 160:00 160:01 
 
 On the 13
th
 day, bioreactor II was harvested. For the harvest process, material was taken 
and centrifuged for 30 minutes at 2100 rpm. Later, the supernatant was frozen at -80
o
C. After 
that day, the experiment was terminated and the material in the bioreactor was decontaminated 
and disposed.  
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4 Results and Discussion 
 In this section of the report, preliminary experiments leading to actual BioXpert run, 
which was described in section 3.1.1, are explained. In addition, results obtained from the actual 
BioXpert run with CHO cells are presented.  
 
4.1 Tubing Calibration 
 Due to the small amount of feed needed for the vessel size, Masterflex SKU 96420-14 
tubing with 1.6 mm internal diameter was selected [21]. It was expected to see deterioration in 
the tubing due to use. To test that, flow rates in both „new‟ and „used‟ portions of the tubing were 
measured. For the „used‟ portion, the tubing was tested at the end of major experiment (BioXpert 
run with CHO cells described in section 3.1.1 after completing seven days of feeding schedule. 
When the flow rates of „new‟ and „used‟ tubing were compared, it was determined that 
performance of the tubing remained constant throughout the experiment. Tubing calibration 
experimental set-up is shown at Figure 8.  
 
 
Figure 8- Tubing calibration experimental set-up 
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4.2 Calibration of Feed Pump 
 The feed pumps were calibrated prior to performing experiments with CHO cells by 
using two techniques: 1) Flow rate and 2) Calibration curve.  
 
4.2.1 Flow Rate Method 
 Deionized (DI) water was used for avoiding complications, which may arise while 
working with nutrient feed solution in sterile. In order to calibrate the feed pump using the flow 
rate method, the amount of liquid going through the system for 3 minutes was measured using a 
graduated cylinder and stopwatch. The measurement was repeated three times, yielding an 
average of 0.075 mL/sec for DI water. By using the flow rate and correcting it for a feed density 
of 1.09 g/mL, the operating time of the pump was calculated. In order to prevent stressing the 
cells due to high amounts of feed, daily feed was into three equal shots per day. To test this, DI 
water was pumped from a bottle to another (placed on separate scales) following the schedule on 
Table 3 with the same experimental setup, which was described in section 4.1. 
 
Table 3- Nutrient solution feeding schedule 
Day          
Shots 
per day 
Daily total feed 
weight (g) 
Feed weight per 
shot (g) 
Feed volume per 
shot (mL) 
Feeding 
duration (sec) 
1 3 17.86 5.95 5.46 73 
2 3 23.35 7.78 7.14 95 
3 3 28.87 9.62 8.83 118 
4 3 31.18 10.39 9.53 127 
5 3 18.55 6.18 5.67 76 
6 3 13.33 4.44 4.07 54 
7 3 7.95 2.65 2.43 32 
  
 The BioXpert algorithm was created using feeding duration information presented in 
Table 3. Feed pump called „pmp 1‟ was defined as „online control variable, digital output‟ in the 
software. Systematic procedure for the experiment is given in Appendix 2.9. The program 
consisted of control statements of „pulse‟ and „on-off‟ functions to control liquid flow from one 
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bottle to the other. With the „on-off function,‟ control statement was considered true (ON), when 
the expression was equal to any value but zero. Therefore, the pump was running when the 
statement was „pmp1=1‟ and was stopping when „pmp1=0‟. Using the „on-off function,‟ the 
pumps were in use for one or more minutes, however, with the „pulse‟ function, it was possible 
to operate the pump for smaller durations, in seconds. For instance, if the statement was 
„pmp1=pulse(13),‟ the pump was working for the first thirteen seconds of recording interval. 
Since the recording interval was set to be 1 minute, the pump was running for thirteen seconds 
every other minute. Using a combination of „on-off‟ and „pulse‟ functions, the algorithm 
presented on Table 4 was created. Since daily feed amount was divided in three, the same control 
statement was repeated three times in 24 hours.  
 
Table 4- BioXpert algorithm used in flow rate method 
Control statement Starting time 
(hr:min) 
Ending time 
(hr:min) 
pmp1= 0 0:00 0:01 
pmp1=1 0:01 0:02 
pmp1=pulse(13) 0:02 0:03 
pmp1=1 8:00 8:01 
pmp1=pulse(13) 8:01 8:02 
pmp1=1 16:00 16:01 
pmp1=pulse(13) 16:01 16:02 
pmp1=1 24:00 24:01 
pmp1=pulse(35) 24:01 24:02 
pmp1=1 32:00 32:01 
pmp1=pulse(35) 32:01 32:02 
pmp1=1 40:00 40:01 
pmp1=pulse(35) 40:01 40:02 
pmp1=1 48:00 48:01 
pmp1=pulse(58) 48:01 48:02 
pmp1=1 56:00 56:01 
pmp1=pulse(58) 56:01 56:02 
pmp1=1 64:00 64:01 
pmp1=pulse(58) 64:01 64:02 
pmp1=1 72:00 72:02 
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pmp1=pulse(7) 72:02 72:03 
pmp1=1 80:00 80:02 
pmp1=pulse(7) 80:02 80:03 
pmp1=1 88:00 88:02 
pmp1=pulse(7) 88:02 88:03 
pmp1=1 96:00 96:01 
pmp1=pulse(16) 96:01 96:02 
pmp1=1 104:00 104:01 
pmp1=pulse(16) 104:01 104:02 
pmp1=11 112:00 112:01 
pmp1=pulse(16) 112:01 112:02 
pmp1=pulse(54) 120:00 120:01 
pmp1=pulse(54) 128:00 128:01 
pmp1=pulse(54) 136:00 136:01 
pmp1=pulse(32) 144:00 144:01 
pmp1=pulse(32) 152:00 152:01 
pmp1=pulse(32) 160:00 160:01 
  At the end of the experiment, it was determined that calculated feeding durations 
were inaccurate and the pump was in 10% to 30% overshooting error. Results obtained during 7-
day feeding schedule are shown in Figure 9. 
 
Figure 9- Results of flow rate method for reactor I 
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4.2.2 Calibration Curve Method 
 For the second run, which entailed the same experimental set-up as described in 4.1, 
nutrient feed solution was used instead of DI water, to solve the overshooting problem and 
acquire more realistic results. Time range for pump to run in “ON” mode was roughly 
determined from the previous experiment as 10 to 130 seconds, and weight data associated with 
that range of time were collected. These weight values were plotted versus time and a curve with 
R
2
 figures of 0.9996 and 0.9984 were obtained for reactor I and II, respectively. Calibration 
curves for reactor I and II are shown in Figure 10 and 11. 
 
Figure 10- Calibration curve for reactor I 
 
Figure 11- Calibration curve for reactor II 
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 As observed from Figure 10 and 11, equation of the fitted curves are W= 0.0945t-0.119 
and W=0.0934t-0.1305 for reactor I and II, respectively. With similar slopes and y-intercepts, it 
was determined that pumps located on different consoles had similar performance. 
 
4.3 Dry Run 
 After obtaining the equations for the two reactors, an experimental dry run was 
performed to verify the calibration curves and feeding algorithm created on BioXpert. Time 
variables (t) in the equations were solved for desired feed weight values (W) by “Goal Seek” 
function on Microsoft Excel. The desired feed values with their corresponding pump operating 
times are presented in Table 5.  
 
Table 5- Feed values with corresponding feeding durations 
      Reactor I  Reactor II 
Feed weight (g) Feeding duration calculated from goal seek (sec) 
5.95 64.22  65.10 
7.78 83.59  84.69 
9.62 103.06  104.40 
10.39 111.21  112.64 
6.18 66.65  67.56 
4.44 48.24  48.93 
2.65 29.30  29.77 
 
 Feed durations calculated from the calibration curves were lower than the ones obtained 
from the flow rate method. Since feed pump was programmed to run for shorter durations, 
calibration curve method was expected to reduce overshooting. Due to BioXpert software‟s 
inability to identify decimal digits, the feeding durations were rounded to next integer. 
Algorithm, presented in Table 6, was created with „pulse‟ functions.  
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Table 6- BioXpert algorithm used in dry run 
Reactor I Reactor II    
Control statement 
Starting 
time 
Ending 
time 
 
pmp1=pulse(59) pmp1=pulse(59) 0:00 0:01  
pmp1=pulse(5) pmp1=pulse(6) 0:01 0:02  
pmp1=pulse(59) pmp1=pulse(59) 0:02 0:03  
pmp1=pulse(25) pmp1=pulse(26) 0:03 0:04  
pmp1=pulse(59) pmp1=pulse(59) 0:04 0:05  
pmp1=pulse(44) pmp1=pulse(45) 0:05 0:06  
pmp1=pulse(59) pmp1=pulse(59) 0:06 0:07  
pmp1=pulse(52) pmp1=pulse(54) 0:07 0:08  
pmp1=pulse(59) pmp1=pulse(59) 0:08 0:09  
pmp1=pulse(8) pmp1=pulse(9) 0:09 0:10  
pmp1=pulse(48) pmp1=pulse(49) 0:10 0:11  
pmp1=pulse(29) pmp1=pulse(30) 0:11 0:12  
 
 Experimental values obtained at the end of the run, were closer to expected values than 
with the previous method and error margin was from -4.5% to 5.8%. Even though these 
percentages appeared to be large, they were negligible for the experiments since they correspond 
to only a change of -0.46 to 0.35 g. and this was considered adequate. The results obtained from 
the dry run of reactor I and II are shown in Figures 12 and 13, respectively.  
 After confirming the accuracy of the BioXpert feeding algorithm, an actual fed-batch run 
with CHO cells using the feed-forward BioXpert algorithm was performed as described in the 
methodology section of the report. 
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Figure 12- Dry run results for reactor I 
 
Figure 13- Dry run results for reactor II 
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4.4 BioXpert Run with CHO Cells Results 
 The growth curves, presented in Figure 14, where the y-axis is removed due to 
confidentiality agreement between ABC and WPI, compare the cell culture performance of the 
current BioXpert feed-forward experiment to previously generated data from manual feed-
forward and feedback experiments. The graphs present the number of viable cells (vc/mL) as a 
function of time (days). Green and pink curves present previously done feedback and manual 
feed-forward experiments performed by Keith Cochran, respectively. Blue curve demonstrates 
the control experiment and purple curve shows the cell density results for the BioXpert feed-
forward run described in section 3 of the report. As displayed in the figure, the feedback 
experiment yielded highest cell density, whereas BioXpert and manual feed-forward experiment 
generated similar results. The control experiment‟s cell density was lower than feedback 
experiments and higher than both of the feed-forward experiments were. 
 
Figure 14- Growth curves 
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 Figure 15, where the y-axis is removed due to confidentiality agreement between ABC 
and WPI, compares the titer performance of the current BioXpert experiment to previously 
generated data from manual feed-forward and feedback experiments This figure shows the 
amount of Monoclonal Antibody (mg/L) produced from CHO cells as a function of time (days). 
The legend of Figure 15 describes the same experiments as for Figure 14. As seen from the 
figure, feedback and BioXpert feed-forward experiments produced similar titer results, whereas 
manual feed-forward experiments had lower titers. Control experiment generated titer results, 
which were lower than previous feedback and both of the feed-forward experiments. 
  
Figure 15- Titer results 
  
 Results of remaining tests, which were discussed in item #4, 5 and 8 of the protocol given 
in section 3.1.1, are presented in Appendix A of the report. Since the information gathered from 
these tests is not pertinent for the results of the experiments, they are not displayed in the main 
body of the report.  
0 2 4 6 8 10 12 14
T
it
e
r 
Time [days]
Control experiment Manual feed-forward experiment
Feedback experiment BioXpert feed-forward experiment
25 
 
5 Conclusion and Recommendations 
 Even though the same total amount of nutrient solution was fed to the bioreactors in each 
of the three experiments (feedback, manual feed-forward and BioXpert feed-forward), each set 
performed quite differently. Reason of this result was the different feeding strategies that were 
used. In the previous feedback experiments, sampling was carried out every two hours and 
feeding performed differently for each shot. For the manual feed-forward experiments, one 
single daily feed was performed. Finally, for the BioXpert feed-forward experiments, the 
solution was fed every 8 hours (3 times daily).  
 The results presented in section 4 and Appendix 1 of the report are not conclusive since 
there are no replicates to demonstrate reproducibility. 
Assuming that the results are accurate, 
 Feed-forward control mechanism was successfully implemented by using feed profiles 
generated from previous feedback experiments. 
 Feed-forward control was applied on the nutrient feed by BioXpert, a SCADA system 
software. 
 The viable cell density results obtained from the BioXpert feed-forward experiments 
were comparable to manual feed-forward experiments but both were lower than the 
feedback experiments. Since both of the feed-forward experiments yielded similarly low 
cell density results, it can be concluded that feedback control had a positive effect on the 
growth of CHO cells. 
 The feedback and BioXpert feed-forward experiments generated similar amounts of 
monoclonal antibody; whereas manual feed-forward experiment produced lower values. 
Therefore, it may be determined that BioXpert algorithm had a positive effect on the 
protein production and helped the feed-forward control strategy to produce improved titer 
results. 
 Levels of pH, partial pressure of CO2, glucose, lactate and osmolality were kept at 
desired values (refer to Appendix A for data). 
 Partial pressure of O2 was mistakenly kept at high values of 78 to 121 mmHg (refer to 
Appendix A for data). Since there were no previous experiments performed at high pO2 
levels, the effect of high range cannot be determined. 
26 
 
Recommendations for future work: 
 The experiments should be repeated with more than 2 replicates to demonstrate 
reproducibility.   
 Current cell line should be maintained to ease comparisons with the BioXpert 
experiments described in this report. 
 Since during the feedback experiment nutrient solution was provided many times per day 
in smaller amounts (and it was the best performing so far), the same strategy, of 12 times 
feeding per day, should be applied. 
 pO2 levels should be kept at ranges (50-70 mmHg) to facilitate comparison of results  
with previous experiments. 
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Appendix 1: Experimental data 
For the graphs that are presented in Appendix A of the report, the y-axes were removed due to 
confidentiality agreement between ABC and WPI. 
 
A1.1. Blood Gas Analyzer Results 
A1.1.1. pH Measurement 
 
Figure A1.1- pH plot 
A1.1.2. Partial Pressure of Oxygen Measurement 
 
Figure A1.2- pO2 plot 
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A1.1.3 Partial Pressure of Carbon Dioxide Measurements 
 
Figure A1.3- pCO2 plot 
 
A1.2. Glucose and Lactate Analyzer Measurements 
A1.2.1. Glucose Measurement 
 
Figure A1.4- Glucose plot 
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A1.2.2. Lactate Measurement 
 
Figure A1.5- Lactate plot 
 
A1.3. Osmometer Measurements 
 
Figure A1.6- Osmolality plot 
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Appendix 2: BioXpert Software 
 In this section of the report, key features of the BioXpert software are detailed and 
procedures for running the software are provided. The information was compiled from official 
BioXpert software [22] and personal experience with the software. For the experiments that are 
described in previous sections of the report, BioXpert NT Version 2.25.091 was used.  
A2.1. Start a new run 
1. To start a new run on BioXpert double click on BioXpert software shortcut from 
the desktop. On the computer number 20203283 in laboratory 3090, there are 
seven shortcuts for BioXpert software on the desktop. It would be best to select 
the shortcut that is associated with the bioreactor that will be used during the 
experiments to avoid any unwanted control process.  
2. After double clicking on the shortcut icon, “New Cultivation or Recalculation 
Window” will appear on computer screen. 
3.  Input user name, program mode and “fermentor number.”  
4. After making the selections, press the “OK” button. Under the “run” tab of the 
software, clicking on “new” will open the “Cultivation Description” dialog, 
displayed in Figure A2-1, where organism name and comments can be inserted. 
5.  After hitting the “OK” button on the “Cultivation Description Dialog” window, 
another dialog box will be opened for putting the name of the file where the data 
collected from the experiment will be saved.  
6. Input the file name and press the “OK” button.  
7. The “Online Session window” will be opened where the start-time of the run, 
elapsed time of the run, online input variables and control values may be observed 
as well as the algorithms and profiles created, may be reached.  
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Figure A2.1 - Cultivation description dialog  
 
A2.2. Define online variables 
1. In order to define an online variable to the BioXpert NT Version 2.25.091, press 
the “variables” button located under the tab menu “install” and input the name of 
the online variable.  
2. Choosing between the “measure” and “control” enables different selections for 
further menus. For instance, the “measure” will give options for “input,” 
“controller output,” “dose monitor,” “value of analog output,” “value of digital 
output,” “status of digital output,” and “value of set-point” for defining the online 
variable. The “control,” will give options for “set-point,” “value of analog 
output,” and “status of digital output.” 
3. Make desired selections and hit “OK” to confirm them. 
 
A2.3. Define offline variable 
 The main function of editing and defining off-line variables window is to introduce a new 
constant value for calculations that may be performed during experiment.  
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1. Offline variables may be defined from “data editor menu” by clicking on “off-
line” and then, “new” buttons.  
2. From the “New variable” window, shown in Figure A2.2, name, scale unit and 
comment for the offline variable are entered.  
3. It is possible to change time intervals of the offline variable. To do so, click on 
“timing” button from “edit offline variables” window.  
4. Clicking on the timing button will initiate another window through which default 
interval and time points may be modified. 
 
Figure A2.2- New variable dialog 
 
A2.4. Define formulas 
 In BioXpert software, formulas may be used for calculations of constants, other formulas, 
on-line and off-line variables. There are already three sets of formulas implemented into the 
software for batch, fed-batch and continuous operating modes.  
1. The formulas can be modified from “edit formulas” window, which is presented 
in Figure A2.3.  
2. New formulas can be entered by clicking on “new” button leading to another 
screen, where name, scale unit and comment of the formula may be defined. 
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3. While defining or modifying the formula, “Items” button can be used to facilitate 
the procedure.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure A2.3- Edit formulas dialog 
 
A2.5. Install new device  
1. In addition to pH, temperature and oxygen probes coupled with the bio console 
and BioXpert software, further devices may be installed on the software through 
“new device” dialog under “install” tab, which leads to another window. 
2. On that window, communication interface between the computer and the new 
device has to be defined as either “ADDA card,” shown in  
Figure A2.4 or “serial port,” displayed in Figure A2.5.  
3. For “ADDA card” selection, the name and I/O port address of the device need to 
be entered and “ADDA card” test may be run to check signals between the device 
and computer.  
4. For the “serial port” option, protocol and com ID are defined to the software. 
Setting of baud rate, data bits, parity and stop bits are changed from “settings” 
button for serial port selection. 
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Figure A2.4- ADDA card test dialog 
 
 
Figure A2.5- Serial port dialog 
 
A2.6. Creating charts 
 Data collected from a BioXpert run may be displayed on a chart window. 
1. To do so, it is necessary to define x and y-axes of the plot from “chart” menu. 
2. “Variables in y-axis,” shown in Figure A2.6, dialog under the “chart” menu 
includes measured and controlled on-line variables, off-line variables, constants, 
formulas and formulas boxes listing all defined variables. Variables that are 
desired for y-axis of the plot may be highlighted from boxes located in the 
window.  
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Figure A2.6- y-axis variable selection dialog 
 
3. Usually “TIME” is selected for the x-axis. However, several other possibilities for 
x-axis variable are listed under “time or variable in x-axis” window, which is 
shown in Figure A2.7.  
4. The selected x-axis of the plot can be highlighted from that window.  
5. In addition, scale range of the axis may be edited by inserting minimum and 
maximum time values in hr:min units to appropriate boxes.  
 
Figure A2.7- x-axis selection dialog 
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6. After selecting the axes, scaling of individual y-axis variables may be edited by 
“scaling settings” window under the “chart” menu.  
7. In addition, it is possible to modify chart area via “chart options” window, which 
can be viewed from the same menu. Inserting a header, name for x-axis, using 
decimal time format, view zero lines, scale units, grid and sample points, as well 
as placing the y-axis name in the chart window may be done through “chart 
options” window.  
8. Once the graph is created, it can be saved from “chart pictures” dialog and be 
viewed later. A plot created on BioXpert is displayed in Figure A2.8. 
Figure A2.8- View of chart 
 
A2.7. Define manual set-point 
 It is possible to control cultivation parameters such as pH, temperature and dissolved 
oxygen level by manually defining setpoints to the software.  
1. In “manual setpoint for …‟ window, displayed in Figure A2.9, value of the set-
point is entered into the box and manual box is checked.  
2. The control starts as soon as user hits OK. 
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Figure A2.9- Set-point dialog 
 
A2.8. Create control algorithm 
 A Control algorithm can be created in order to regulate control for one or more variables 
over time.  
1. In the “control algorithm” window; first, the name of the algorithm is entered, and 
then control statements are listed with their starting and ending times. In that 
window, displayed in Figure A2.10, control interval is displayed in 
minutes:seconds in either “R” (reading interval) mode, “C” (custom interval) 
mode or “C+” (custom interval with synchronization with reading moment) mode. 
2.  For control, statements such as “IF…ELSE … ENDIF,” “variable=expression,” 
“-nr,nr,…,” “+nr, nr,…,” “GOTO nr” and “STOP” functions can be used. 
Additionally, Applikon bio technical services can provide support with additional 
functions.  
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Figure A2.10 - Control statement dialog 
 
A2.9. Step-by-step Procedure  
1. Using the computer number 20203283 in laboratory 3090, click on BioXpert icon 
corresponding to the number of bioreactor that you are working with. 
2. After double clicking on the shortcut icon, “New Cultivation or Recalculation Window” 
will appear on computer screen. 
3. Select user name. Input program mode as “cultivation” and check to see that the 
“fermentor number” matches with the number of reactor that is being used. 
4. After entering necessary information, press the “OK” button.  
5. Under the “run” menu, click on “new.” 
6. Enter organism name and comments, if desired, to appropriate boxes and click “OK.” 
7. After hitting “OK,” “Cultivation parameter” window will appear on the computer screen. 
8. Make sure that “access interval” is 1 minute. 
9. Input the file name describing the experiment in “protocol data” box and press the “OK” 
button.  
10. The “Online Session window” will be opened. 
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11. To define feed pump, click on “variables” from “install” menu. 
12. Make sure that the device name is “AD11040(x)” where x represents the number of 
bioreactor that is in use. 
13. Input the name of the online variable as “pmp1.”  
14. Define the pump as “control” and “status of digital output.”  
15. Input descriptive comment such as “nutrient feed pump.” (Units box may be left blank) 
16. Choose “1” for channel number and hit “ADD,” and click on “DONE” to confirm. 
17. Enter the setpoint values for temperature, pH and dO2 from “manual setpoint for…” 
window and check the “manual” box and hit “OK.” 
18. From “control laws menu”, click on “manual setpoint” and select variable that will be 
manually controlled (e.g. pHC and temperature). 
19. Input the setpoint value to “manual setpoint” window and click “OK.” Repeat steps 18 & 
19 if there are more than one variable controlled manually. 
20. Go back to “on-line session” window. 
21. Click on “algorithm” and copy the algorithm pattern given in section 3, on Table 2. 
22. After completing the algorithm, click on “CHECK” to see if there are any mistakes in the 
algorithm such as undefined variables or statements. 
23. If there is no error on the algorithm, click on “DONE.”  
24. Once the algorithm is created, set the feed pump to “remote” mode from the console that 
is located on the bench, next to bioreactor that is in use. 
25. To stop the experiment, click on “END” from the “on-line session window.”  
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Appendix 3: Properties for test machines  
 
A3.1. Blood Gas Analyzer 
The information below was taken from official website of the manufacturer, YSI [23]. 
YSI 2700 SELECT Bioprocess Monitoring  
Fermentations and cell cultures require tight control of system variables to achieve consistent, 
desirable results. Regulating variables such as oxygen, pH, and temperature has long been 
accepted as important for assuring viable processes. More recently, researchers have recognized 
the need to regulate nutrients and byproducts as well, and have determined that controlling them 
plays a vital role in the health and productivity of their processes. 
 
The YSI 2700 SELECT
TM
 Biochemistry Analyzer 
provides vital information about your processes. 
It provides rapid, accurate analysis of key 
nutrients and byproducts, including:  
 Glucose  
 L-Lactate  
 L-Glutamine  
 L-Glutamate  
 Ethanol  
 Lactose  
 Sucrose  
 Galactose  
 Hydrogen peroxide  
 Methanol 
 
Sample analysis can be done two ways, off-line or on-line.  
Off-Line Analysis 
For many processes, off-line analysis is a good method for monitoring nutrients or byproducts, 
particularly if consumption or production rates are slow. As a benchtop analyzer, the YSI 2700 
SELECT is easy to use and provides results quickly—in 60 seconds. Sample volume 
requirements are low (about 25 µL) which allow you to run as many samples as you want. And 
the best feature of all is that no sample preparation is required (no filtration and no dilution in 
most cases). 
 
Specifications 
 
YSI 2700 Analyzer 
  
 
Aspirated sample volume:  
 
 
User selects 5 to 65 microliters 
 
Analysis time:  
 
 
60 seconds 
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Precision:  <2% CV, n=10 
 
Linearity:  
 
 
±5%, calibration value to range maximum 
 
Calibration:  
 
 
User selects frequency 
 
Size:  
 
 
35.6 x 25.4 x 35.6 cm, 11.4 kg  
(14 x 10 x 14 inches, 25 lbs) 
 
Working environment:  
 
 
15 to 35°C ambient temperature,  
10 to 90% relative humidity (noncondensing) 
 
Power:  
 
 
110-120 VAC or 220-240 VAC 
50-60 Hz 
50 Watts nominal 
 
Battery backup:  
 
 
Rechargeable Ni-Cad batteries to back up RAM. 
 
Regulatory Compliance: 
 
 
CE, CSA 
 
Analog/Control  
 
Full Scale Voltage:  
 
 
Selectable: +10.00 VDC or +5.00 VDC 
 
Full Scale Concentration:  
 
 
User selectable via software as 1, 2, 3 or  
4 x Calibrant Concentration.  
 
Resolution:  
 
 
1:4096 or 0.02% FS, 2.44 mV on +10.00 VFS, 1.22 
mV on +5.00 VFS 
 
Maximum Offset:  
 
 
±4 LSB 
 
Linearity:  
 
 
±1 LSB  
 
Minimum analog output  
Load Impedance:  
 
 
. 
2K Ohms 
 
Logic output drive:  
 
 
0 and 5 VDC nominal at 4 mA 
 
Logic Input levels:  
 
 
< 0.8 VDC = logic 0,  
> 3.5 VDC = logic 1 
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A3.2. Biochemistry Analyzer 
The information below was taken from official website of the manufacturer, Radiometer [24] . 
Radiometer ABL5   
Fulfill your basic critical care testing needs 
  Measures pH, pCO2 and pO2 from 85 µL whole-
blood sample  
Improve cost efficiency 
 High reliability, stability and standby function 
reduce operating costs  
 Cost-effective analyzer - especially for units 
running only few tests per day  
Simplify your work routine 
 Easy sample introduction  
 Intuitive user interface  
 Minimum maintenance  
 Simple replacement of solutions 
 
 
pH 
pCO2 
pO2  
  
 
 
  
45 
 
A3.3. Cell Density Examination (CEDEX) System 
The information below was taken from official website of the manufacturer, Innovatis [25]and 
Dianova Inc website [26]. 
Product Description 
 The Cedex is the first automated cell counting system based on the well-established Trypan 
Blue exclusion method for determining cell viability. 
Designed by innovatis AG in 1995, the proven technology 
has become the "Industry Gold Standard" in the 
pharmaceutical and biotechnology industries. Today, more 
than 600 systems are in operation world-wide.  
 Cell count and cell viability are two of the most 
important parameters in cell culture related production and 
research. Traditionally, these parameters are determined 
manually with the aid of a microscope and a hemacytometer 
after staining the cells with Trypan blue.  
 However, manual counting is known to be time-
intensive, user-dependent and not reliable.  
 The Cedex has automated the manual method in 
order to provide the user with more accurate and precise data about cell count, viability and additional 
important parameters within minutes. 
Sample handling, staining, cell counting and graphical analysis of the results are performed 
automatically by the Cedex. The result data are self-explanatory and can easily be archived. The 
optional MS 20 Multisampler can convey up to 20 samples in sequence to the Cedex measurement 
without the need for user interference.  
 The hardware can be easily integrated into existing networks. 
Integration of the Cedex technology into automated process lines can 
be achieved via a Telnet port (TCP/IP Protocol) based on a "Remote 
Control" software feature. innovatis AG also offers integration 
services for existing Laboratory Information Management Systems 
(LIMS). The Cedex technology has been proven to fit into GMP 
processes and complies with the requirements of 21 CFR Part 11.  
Measurement results of Cedex: 
 cell viability  
 cell density  
 cell size  
 cell morphology 
 aggregation rate 
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Technical Description 
 
Method of measurement Digital image recognition 
Viable/dead cell differentiation Trypan Blue Exclusion Method 
Detectable cell density range 5 x 104 - 1 x 107 cells per mL 
Detectable cell diameter range 8 µm - 40 µm 
Required sample volume 1000 µL 
Average measurement period < 4,0 min 
Geometric resolution 2.1 µm/Pixel 
Chamber height 100 µm 
Material and Diameter of the 
capillaries 
Teflon, 765 µm 
Operating temperature (Optimal 
image quality is achieved between 
20 °C and 30 °C) 
10 °C - 35 °C (50 °F - 95 °F) 
Operating humidity 20 % - 80 % relative humidity 
(non-condensing) 
Dimensions (Height/Width/Depth) 660 mm / 300 mm / 500 mm 
Weight 34 kg 
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Energy requirements 100 - 250 VAC, 50 - 60 Hz 
Energy consumption 60 W 
Computer 
Operating system Windows XP® Professional 
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A3.4. Osmometer 
The information below was taken from official website of the manufacturer, Advanced 
Instruments [27]. 
The Advanced Model 3900 Multi-Sample Osmometer is designed to 
automate testing for laboratories processing moderate to high volumes of 
samples. By using the industry-preferred method of freezing-point 
technology for an accurate determination of total concentration, combined 
with high, continuous throughput, the Advanced Instruments Model 3900 
will provide your laboratory optimal efficiency - easily accurately, and 
reliably.  
 Applications: 
 Clinical Medicine  
 Medical Research  
 IVD Test Development  
 Bio-Processor Control  
 Biopharmaceutical Monitoring  
 Exercise Physiology and Athletic Conditioning  
Key Features: 
 Continuous Throughput for Increased Productivity  
 Tamper-Proof Results  
 Full Automation  
 STAT Capability  
 Unmatched Customer 
Service  
 
Model 3900 Multi-Sample Osmometer Specifications 
Sample Volume 0.2 to 0.3 mL (glass or disposable plastic tubes)  
Test Time 90 seconds per sample typical 
Sample Throughput Approximately 30 samples per hour  
Sample Capacity Up to 30 samples at one time, continuously re-loadable  
Units mOsm/kg H2O  
Resolution 1 mOsm/kg H2O 
Range Low: 0 to 1550 mOsm/kg H2O 
  High: 1450-4000 mOsm/kg H2O 
Communications On-board printer, DTE RS-232 serial port, and optional barcode scanner 
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Performance at Reference Conditions* 
Linearity Low Range: Less than ±0.5% from a straight line between 0 and 1500 
mOsm/kg H2O 
  High Range: Less than ±1.0% from a straight line between 1500 and 4000 
mOsm/kg H2O 
Repeatability ±2 mOsm/kg H2O (1 S.D.) between 0 and 400 mOsm/kg H2O; ±0.5% 
(1 S.D.) between 400 and 4000 mOsm/kg H2O 
Drift Less than 1 mOsm/kg H2O per month 
Performance Over Operating Conditions 
Temperature Effects Less than 1 mOsm/kg H2O per 5° C (9°F) ambient temperature change 
Operating Conditions  
Temperature Low Range: 18 to 35°C (64 to 95°F) 
  High Range: 18 to 30°C (64 to 86 °F) 
Humidity 5 to 80% relative humidity, (non-condensing) 
Storage Temperature -40 to +45°C (-40 to +113°F)  
Electrical  
Voltage 100 to 130 VAC (50-60 Hz) or  
  200 to 250 VAC (50/60 Hz) 
Power Consumption 350 Watts 
Dimensions 21.5" H x 21.5" W x 20.0 " D (54.6 cm x 54.6 cm x 50.8 cm) 
Net Weight 66.0 lbs. (30.0 kg) 
Shipping Weight 105.0 lbs. (47.7kg) 
Warranty One-year limited warranty on workmanship and all parts except glass, plastic, 
and parts warranted by their makers  
Certification 
 
  
*Reference Conditions 20 to 25°C (68 to 77°F); 40 to 60% relative humidity; tolerances of reference or 
calibration solutions excluded 
For more information on the Advanced Instruments family of tests, please call 800-225-4034  
 
